Our analysis of immune infiltrates in human colon cancer and AOM-DSS mouse CAC model indicated that GPR15 expression may modulate the relative abundance of innate and adaptive immune cell subsets as well as cytokine secreting, effector T cell subsets in the colon tumor microenvironment (TME) in favor of tumor regression. This evidence concerns the gene GPR15 and neoplasm.